1
|
Lemenze A, Mittal N, Perryman AL, Daher SS, Ekins S, Occi J, Ahn YM, Wang X, Russo R, Patel JS, Daugherty RM, Wood DO, Connell N, Freundlich JS. Rickettsia Aglow: A Fluorescence Assay and Machine Learning Model to Identify Inhibitors of Intracellular Infection. ACS Infect Dis 2022; 8:1280-1290. [PMID: 35748568 PMCID: PMC9912140 DOI: 10.1021/acsinfecdis.2c00014] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/12/2023]
Abstract
Rickettsia is a genus of Gram-negative bacteria that has for centuries caused large-scale morbidity and mortality. In recent years, the resurgence of rickettsial diseases as a major cause of pyrexias of unknown origin, bioterrorism concerns, vector movement, and concerns over drug resistance is driving a need to identify novel treatments for these obligate intracellular bacteria. Utilizing an uvGFP plasmid reporter, we developed a screen for identifying anti-rickettsial small molecule inhibitors using Rickettsia canadensis as a model organism. The screening data were utilized to train a Bayesian model to predict growth inhibition in this assay. This two-pronged methodology identified anti-rickettsial compounds, including duartin and JSF-3204 as highly specific, efficacious, and noncytotoxic compounds. Both molecules exhibited in vitro growth inhibition of R. prowazekii, the causative agent of epidemic typhus. These small molecules and the workflow, featuring a high-throughput phenotypic screen for growth inhibitors of intracellular Rickettsia spp. and machine learning models for the prediction of growth inhibition of an obligate intracellular Gram-negative bacterium, should prove useful in the search for new therapeutic strategies to treat infections from Rickettsia spp. and other obligate intracellular bacteria.
Collapse
Affiliation(s)
- Alexander Lemenze
- Department of Medicine, and the Ruy V. Lourenco Center for the Study of Emerging and Reemerging Pathogens, Rutgers University - New Jersey Medical School, Newark, New Jersey 07103, United States; Present Address: Department of Pathology, Immunology, and Laboratory Medicine, Rutgers University - New Jersey Medical School, Cancer Center Building, 205 South Orange Avenue, Newark, New Jersey 07103, United States
| | - Nisha Mittal
- Department of Pharmacology, Physiology, and Neuroscience, Rutgers University - New Jersey Medical School, Newark, New Jersey 07103, United States; Present Address: Bristol Myers Squibb, 1 Squibb Drive, Building 85 Room A-WS216D, New Brunswick, New Jersey 08901, United States
| | - Alexander L. Perryman
- Department of Pharmacology, Physiology, and Neuroscience, Rutgers University - New Jersey Medical School, Newark, New Jersey 07103, United States; Present Address: Repare Therapeutics, 7171 Rue Frederick-Banting, Montreal, Quebec H4S 1Z9, Canada
| | - Samer S. Daher
- Department of Pharmacology, Physiology, and Neuroscience, Rutgers University - New Jersey Medical School, Newark, New Jersey 07103, United States; Present Address: Ambrx, 10975 N. Torrey Pines Road, La Jolla, California 92037, United States
| | - Sean Ekins
- Collaborations in Chemistry, Fuquay-Varina, North Carolina 27526, United States; Present Address: Collaborations Pharmaceuticals, Inc., Main Campus Drive, Lab 3510 Raleigh, North Carolina 27606, United States
| | - James Occi
- Department of Medicine, and the Ruy V. Lourenco Center for the Study of Emerging and Reemerging Pathogens, Rutgers University - New Jersey Medical School, Newark, New Jersey 07103, United States; Present Address: Center for Vector Biology, Department of Entomology, Rutgers University, 180 Jones Avenue, New Brunswick, New Jersey 08901, United States
| | - Yong-Mo Ahn
- Department of Pharmacology, Physiology, and Neuroscience, Rutgers University - New Jersey Medical School, Newark, New Jersey 07103, United States
| | - Xin Wang
- Department of Pharmacology, Physiology, and Neuroscience, Rutgers University - New Jersey Medical School, Newark, New Jersey 07103, United States; Present Address: Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, Boston, Massachusetts 02115, United States
| | - Riccardo Russo
- Department of Medicine, and the Ruy V. Lourenco Center for the Study of Emerging and Reemerging Pathogens, Rutgers University - New Jersey Medical School, Newark, New Jersey 07103, United States
| | - Jimmy S. Patel
- Department of Pharmacology, Physiology, and Neuroscience, Rutgers University - New Jersey Medical School, Newark, New Jersey 07103, United States; Present Address: Department of Radiation Oncology, Winship Cancer Institute of Emory University, 1365-A Clifton Road NE, Atlanta, Georgia 30322, United States
| | - Robin M. Daugherty
- Department of Microbiology and Immunology, University of South Alabama, Mobile, Alabama 36688, United States
| | - David O. Wood
- Department of Microbiology and Immunology, University of South Alabama, Mobile, Alabama 36688, United States
| | - Nancy Connell
- Department of Medicine, and the Ruy V. Lourenco Center for the Study of Emerging and Reemerging Pathogens, Rutgers University - New Jersey Medical School, Newark, New Jersey 07103, United States; Present Address: U.S. National Academies of Science, Engineering and Medicine, 500 5th Street NW, Washington, District of Columbia 20002, United States
| | - Joel S. Freundlich
- Department of Medicine, and the Ruy V. Lourenco Center for the Study of Emerging and Reemerging Pathogens and Department of Pharmacology, Physiology, and Neuroscience, Rutgers University - New Jersey Medical School, Newark, New Jersey 07103, United States
| |
Collapse
|
2
|
Strand A, Paddock CD, Rinehart AR, Condit ME, Marus JR, Gillani S, Chung IH, Fowler VG. African Tick Bite Fever Treated Successfully With Rifampin in a Patient With Doxycycline Intolerance. Clin Infect Dis 2017; 65:1582-1584. [PMID: 28505276 PMCID: PMC5850440 DOI: 10.1093/cid/cix363] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/28/2017] [Accepted: 05/10/2017] [Indexed: 11/12/2022] Open
Abstract
African tick bite fever is the most commonly encountered travel-associated rickettsiosis, occurring in as many as 5% of travelers returning from rural subequatorial Africa. This case report illustrates that rifampin represents an effective alternative to doxycycline for treatment of African tick bite fever in some selective situations.
Collapse
Affiliation(s)
- Andrew Strand
- Division of Infectious Diseases, Duke University Medical Center, Durham, North Carolina
| | - Christopher D Paddock
- Rickettsial Zoonoses Branch, Centers for Disease Control and Prevention, Atlanta, Georgia; and
| | | | - Marah E Condit
- Rickettsial Zoonoses Branch, Centers for Disease Control and Prevention, Atlanta, Georgia; and
| | - Jessica R Marus
- Rickettsial Zoonoses Branch, Centers for Disease Control and Prevention, Atlanta, Georgia; and
| | - Shezeen Gillani
- Rickettsial Zoonoses Branch, Centers for Disease Control and Prevention, Atlanta, Georgia; and
| | - Ida H Chung
- Rickettsial Zoonoses Branch, Centers for Disease Control and Prevention, Atlanta, Georgia; and
| | - Vance G Fowler
- Division of Infectious Diseases, Duke University Medical Center, Durham, North Carolina
| |
Collapse
|
3
|
Delord M, Socolovschi C, Parola P. Rickettsioses and Q fever in travelers (2004-2013). Travel Med Infect Dis 2014; 12:443-58. [PMID: 25262433 DOI: 10.1016/j.tmaid.2014.08.006] [Citation(s) in RCA: 44] [Impact Index Per Article: 4.4] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/13/2014] [Revised: 08/27/2014] [Accepted: 08/27/2014] [Indexed: 11/17/2022]
Abstract
Rickettsioses (also called typhus) are associated with arthropods, including ticks, mites, fleas, and lice, although Q fever is more frequently acquired through the inhalation of contaminated aerosols or the consumption of milk. These zoonoses first emerged in the field of travel medicine 20 years ago. Here, we review rickettsioses and Q fever in travelers, highlighting cases reported in the past decade. African tick bite fever and Mediterranean spotted fever are the two most frequent spotted fevers. While the presentation of these fevers is typically benign, cardiac and neurological complications due to African tick bite fever have been reported, and Mediterranean spotted fever has been complicated by multi-organ failure and death in a few cases. Murine typhus and Q fever remain difficult to recognize and diagnose because these illnesses often present with only fever. New molecular tools, particularly when deployed with samples obtained from eschar swabs, might be easily implemented in laboratories with PCR facilities. Doxycycline must be introduced upon clinical suspicion of rickettsioses or Q fever and should be considered in cases of fever of unknown origin in travelers who are returning from at-risk geographic areas.
Collapse
Affiliation(s)
- Marion Delord
- Assistance Publique Hôpitaux de Marseille, Pole Maladies Infectieuses, Hôpital Nord, Marseille, France
| | - Cristina Socolovschi
- Aix Marseille Université, Unité de Recherche en Maladies Infectieuses et Tropicales Emergentes (URMITE), UM63, CNRS 7278, IRD 198 (Dakar), Inserm 1095, WHO Collaborative Center for Rickettsioses and Other Arthropod-borne Bacterial Diseases, Marseille, France
| | - Philippe Parola
- Assistance Publique Hôpitaux de Marseille, Pole Maladies Infectieuses, Hôpital Nord, Marseille, France; Aix Marseille Université, Unité de Recherche en Maladies Infectieuses et Tropicales Emergentes (URMITE), UM63, CNRS 7278, IRD 198 (Dakar), Inserm 1095, WHO Collaborative Center for Rickettsioses and Other Arthropod-borne Bacterial Diseases, Marseille, France.
| |
Collapse
|